BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du L, Cheng Z, Zhang Y, Li Y, Mei D. The impact of medication adherence on clinical outcomes of coronary artery disease: A meta-analysis. Eur J Prev Cardiolog 2017;24:962-70. [DOI: 10.1177/2047487317695628] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Garcia RA, Spertus JA, Benton MC, Jones PG, Mark DB, Newman JD, Bangalore S, Boden WE, Stone GW, Reynolds HR, Hochman JS, Maron DJ; ISCHEMIA Research Group. Association of Medication Adherence With Health Outcomes in the ISCHEMIA Trial. J Am Coll Cardiol 2022;80:755-65. [PMID: 35981820 DOI: 10.1016/j.jacc.2022.05.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhou Y, Huo Q, Du S, Shi X, Shi Q, Cui S, Feng C, Du X, Wang Y. Social Support and Self-Efficacy as Mediating Factors Affecting the Association Between Depression and Medication Adherence in Older Patients with Coronary Heart Disease: A Multiple Mediator Model with a Cross-Sectional Study. PPA 2022;Volume 16:285-95. [DOI: 10.2147/ppa.s337634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mark DG, Shan J, Huang J, Ballard DW, Vinson DR, Kene MV, Sax DR, Rauchwerger AS, Reed ME; Kaiser Permanente CREST Network Investigators. Higher intensity of 72-h noninvasive cardiac test referral does not improve short-term outcomes among emergency department patients with chest pain. Acad Emerg Med 2022. [PMID: 35064989 DOI: 10.1111/acem.14448] [Reference Citation Analysis]
4 Yu M, Wang L, Guan L, Qian M, Lv J, Deng M. Knowledge, attitudes, and barriers related to medication adherence of older patients with coronary heart disease in China. Geriatr Nurs 2021;43:235-41. [PMID: 34952306 DOI: 10.1016/j.gerinurse.2021.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Plakht Y, Gilutz H, Shiyovich A. When More Means Less: The Prognosis of Recurrent Acute Myocardial Infarctions. J Clin Med 2021;10:5889. [PMID: 34945184 DOI: 10.3390/jcm10245889] [Reference Citation Analysis]
6 Fröbert O, Götberg M, Erlinge D, Akhtar Z, Christiansen EH, MacIntyre CR, Oldroyd KG, Motovska Z, Erglis A, Moer R, Hlinomaz O, Jakobsen L, Engstrøm T, Jensen LO, Fallesen CO, Jensen SE, Angerås O, Calais F, Kåregren A, Lauermann J, Mokhtari A, Nilsson J, Persson J, Stalby P, Islam AKMM, Rahman A, Malik F, Choudhury S, Collier T, Pocock SJ, Pernow J. Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Circulation 2021;144:1476-84. [PMID: 34459211 DOI: 10.1161/CIRCULATIONAHA.121.057042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
7 Świątkiewicz I, Di Somma S, De Fazio L, Mazzilli V, Taub PR. Effectiveness of Intensive Cardiac Rehabilitation in High-Risk Patients with Cardiovascular Disease in Real-World Practice. Nutrients 2021;13:3883. [PMID: 34836144 DOI: 10.3390/nu13113883] [Reference Citation Analysis]
8 Pavy B, Iliou MC, Guy JM, Tabet JY, Ponchon-Weess A, Pierre B, Blonde MC, Bire F, Paemelaere F, Bosser G, Blanc P, Gebuhrer V, Carré F; group of exercise rehabilitation sport prevention (GERSP) of the French Society of Cardiology. MEdical TReatment Optimization in cardiac rehabilitation (METRO study) : a French multicenter study. Ann Cardiol Angeiol (Paris) 2021;70:275-80. [PMID: 34635328 DOI: 10.1016/j.ancard.2021.08.009] [Reference Citation Analysis]
9 Padilha JC, Santos VB, Lopes CT, Lopes JL. Prevalence of pharmacological adherence in patients with coronary artery disease and associated factors. Rev Lat Am Enfermagem 2021;29:e3464. [PMID: 34495187 DOI: 10.1590/1518-8345.4554.3464] [Reference Citation Analysis]
10 Tesfaye W, Peterson G. Self-reported medication adherence measurement tools: Some options to avoid a legal minefield. J Clin Pharm Ther 2021. [PMID: 34431554 DOI: 10.1111/jcpt.13515] [Reference Citation Analysis]
11 Schwaab B, Bjarnason-Wehrens B, Meng K, Albus C, Salzwedel A, Schmid JP, Benzer W, Metz M, Jensen K, Rauch B, Bönner G, Brzoska P, Buhr-Schinner H, Charrier A, Cordes C, Dörr G, Eichler S, Exner AK, Fromm B, Gielen S, Glatz J, Gohlke H, Grilli M, Gysan D, Härtel U, Hahmann H, Herrmann-Lingen C, Karger G, Karoff M, Kiwus U, Knoglinger E, Krusch CW, Langheim E, Mann J, Max R, Metzendorf MI, Nebel R, Niebauer J, Predel HG, Preßler A, Razum O, Reiss N, Saure D, von Schacky C, Schütt M, Schultz K, Skoda EM, Steube D, Streibelt M, Stüttgen M, Stüttgen M, Teufel M, Tschanz H, Völler H, Vogel H, Westphal R. Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 2. J Clin Med 2021;10:3071. [PMID: 34300237 DOI: 10.3390/jcm10143071] [Reference Citation Analysis]
12 Giordano NA, Riman KA, French R, Daus M, Stephens-Shields AJ, Kimmel SE, Riegel B. Comparing medication adherence using a smartphone application and electronic monitoring among patients with acute coronary syndrome. Appl Nurs Res 2021;60:151448. [PMID: 34247788 DOI: 10.1016/j.apnr.2021.151448] [Reference Citation Analysis]
13 Camila de Souza Groia Veloso R, Cruzeiro MGM, Dias BM, Reis AMM. Assessment of adherence to statin therapy in patients with coronary artery disease: comparison of three self-reporting measures. Eur J Hosp Pharm 2021:ejhpharm-2021-002725. [PMID: 34031152 DOI: 10.1136/ejhpharm-2021-002725] [Reference Citation Analysis]
14 Sotorra-Figuerola G, Ouchi D, Giner-Soriano M, Morros R. Impact of adherence to drugs for secondary prevention on mortality and cardiovascular morbidity: A population-based cohort study. IMPACT study. Pharmacoepidemiol Drug Saf 2021;30:1250-7. [PMID: 33938603 DOI: 10.1002/pds.5261] [Reference Citation Analysis]
15 Zyryanov SK, Fitilev SB, Vozzhaev AV, Shkrebneva II, Shindryaeva NN, Klyuev DA, Stepanyan LN, Lutsenko AM, Tsai AT, Danilova AA. Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:178-85. [DOI: 10.20996/1819-6446-2021-03-03] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Si MY, Su XY, Jiang Y, Wang WJ, Gu XF, Ma L, Li J, Zhang SK, Ren ZF, Liu YL, Qiao YL. Prevalence and Predictors of PTSD During the Initial Stage of COVID-19 Epidemic among Female College Students in China. Inquiry 2021;58:469580211059953. [PMID: 34933595 DOI: 10.1177/00469580211059953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Gimelli A, Pugliese NR, Buechel RR, Coceani M, Clemente A, Kaufmann PA, Marzullo P. Myocardial perfusion scintigraphy for risk stratification of patients with coronary artery disease: the AMICO registry. Eur Heart J Cardiovasc Imaging 2020:jeaa298. [PMID: 33247905 DOI: 10.1093/ehjci/jeaa298] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Werba JP, Bonomi A, Giroli M, Amato M, Vigo L, Agrifoglio M, Alamanni F, Cavallotti L, Kassem S, Naliato M, Parolari A, Penza E, Polvani G, Pompilio G, Porqueddu M, Roberto M, Salis S, Zanobini M, Amato M, Baldassarre D, Veglia F, Tremoli E. Long-term secondary cardiovascular prevention programme in patients subjected to coronary artery bypass surgery. Eur J Prev Cardiol 2020:zwaa060. [PMID: 33624003 DOI: 10.1093/eurjpc/zwaa060] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Rachamin Y, Markun S, Grischott T, Rosemann T, Meier R. Guideline Concordance of Statin Treatment Decisions: A Retrospective Cohort Study. J Clin Med 2020;9:E3719. [PMID: 33228169 DOI: 10.3390/jcm9113719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Karataş T, Polat Ü. Effect of nurse-led program on the exercise behavior of coronary artery patients: Pender's Health Promotion Model. Patient Educ Couns 2021;104:1183-92. [PMID: 33129630 DOI: 10.1016/j.pec.2020.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Hattler B, Grover FL, Wagner T, Hawkins RB, Quin JA, Collins JF, Bishawi M, Almassi H, Shroyer AL; Veterans Affairs Randomized On/Off Bypass Follow-up Study (ROOBY-FS) Group. Incidence and Prognostic Impact of Incomplete Revascularization Documented by Coronary Angiography 1 Year After Coronary Artery Bypass Grafting. Am J Cardiol 2020;131:7-11. [PMID: 32718555 DOI: 10.1016/j.amjcard.2020.06.047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 De Luca L, Temporelli PL, Riccio C, Gonzini L, Marinacci L, Tartaglione SN, Costa P, Scherillo M, Senni M, Colivicchi F, Gulizia MM; START Investigators. Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study. Eur Heart J Qual Care Clin Outcomes 2019;5:334-42. [PMID: 30649303 DOI: 10.1093/ehjqcco/qcz002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
23 Plakht Y, Greenberg D, Gilutz H, Arbelle JE, Shiyovich A. Mortality and healthcare resource utilization following acute myocardial infarction according to adherence to recommended medical therapy guidelines. Health Policy 2020;124:1200-8. [PMID: 32709369 DOI: 10.1016/j.healthpol.2020.07.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Palmer K, Monaco A, Kivipelto M, Onder G, Maggi S, Michel JP, Prieto R, Sykara G, Donde S. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing. Aging Clin Exp Res 2020;32:1189-94. [PMID: 32458356 DOI: 10.1007/s40520-020-01601-4] [Cited by in Crossref: 136] [Cited by in F6Publishing: 110] [Article Influence: 68.0] [Reference Citation Analysis]
25 Lopez-Jimenez F, Gersh BJ. Secondary prevention after coronary artery bypass grafting saves lives: a golden opportunity often wasted. Eur Heart J 2020;41:1662-4. [PMID: 31800026 DOI: 10.1093/eurheartj/ehz855] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, Iliou MC, Pedretti RF, Schmid JP, Vigorito C, Voller H, Wilhelm M, Piepoli MF, Bjarnason-Wehrens B, Berger T, Cohen-Solal A, Cornelissen V, Dendale P, Doehner W, Gaita D, Gevaert AB, Kemps H, Kraenkel N, Laukkanen J, Mendes M, Niebauer J, Simonenko M, Zwisler AO. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol 2020;:2047487320913379. [PMID: 32223332 DOI: 10.1177/2047487320913379] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 34.0] [Reference Citation Analysis]
27 Carney K, Thande N, Gosch K, Desai N. Relationship Between Provider Experience and Cardiac Performance Measures in Outpatients (from the NCDR). Am J Cardiol 2020;125:820-6. [PMID: 31898968 DOI: 10.1016/j.amjcard.2019.11.027] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol 2019;4:206-13. [PMID: 30758506 DOI: 10.1001/jamacardio.2018.4936] [Cited by in Crossref: 81] [Cited by in F6Publishing: 68] [Article Influence: 40.5] [Reference Citation Analysis]
29 Sua YS, Jiang Y, Thompson DR, Wang W. Effectiveness of mobile phone-based self-management interventions for medication adherence and change in blood pressure in patients with coronary heart disease: A systematic review and meta-analysis. Eur J Cardiovasc Nurs 2020;19:192-200. [PMID: 31856596 DOI: 10.1177/1474515119895678] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
30 Bailey SC, Wallia A, Wright S, Wismer GA, Infanzon AC, Curtis LM, Brokenshire SA, Chung AE, Reuland DS, Hahr AJ, Hornbuckle K, Lockwood K, Hall L, Wolf MS. Electronic Health Record-Based Strategy to Promote Medication Adherence Among Patients With Diabetes: Longitudinal Observational Study. J Med Internet Res 2019;21:e13499. [PMID: 31638592 DOI: 10.2196/13499] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
31 Birck MG, Goulart AC, Lotufo PA, Benseñor IM. Secondary prevention of coronary heart disease: a cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Sao Paulo Med J 2019;137:223-33. [PMID: 31483010 DOI: 10.1590/1516-3180.2018.0531140319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
32 Ruscica M, Tokgözoğlu L, Corsini A, Sirtori CR. PCSK9 inhibition and inflammation: A narrative review. Atherosclerosis 2019;288:146-55. [PMID: 31404822 DOI: 10.1016/j.atherosclerosis.2019.07.015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
33 Ni Z, Dardas L, Wu B, Shaw R. Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review. Heart Asia 2019;11:e011173. [PMID: 31297162 DOI: 10.1136/heartasia-2018-011173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Sirtori CR, Yamashita S, Greco MF, Corsini A, Watts GF, Ruscica M. Recent advances in synthetic pharmacotherapies for dyslipidaemias. Eur J Prev Cardiolog 2020;27:1576-96. [DOI: 10.1177/2047487319845314] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
35 Parker WAE, Orme RC, Hanson J, Stokes HM, Bridge CM, Shaw PA, Sumaya W, Thorneycroft K, Petrucci G, Porro B, Judge HM, Ajjan RA, Rocca B, Storey RF. Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Platelets 2019;30:148-57. [PMID: 30759035 DOI: 10.1080/09537104.2019.1572880] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
36 Cimminiello C, Dondi L, Pedrini A, Ronconi G, Calabria S, Piccinni C, Polo Friz H, Martini N, Maggioni AP. Patterns of treatment with antiplatelet therapy after an acute coronary syndrome: Data from a large database in a community setting. Eur J Prev Cardiol 2019;26:836-46. [PMID: 30477319 DOI: 10.1177/2047487318814970] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
37 Sabidó M, Thilo H, Guido G. Long-term effectiveness of bisoprolol in patients with angina: A real-world evidence study. Pharmacol Res 2019;139:106-12. [PMID: 30408572 DOI: 10.1016/j.phrs.2018.10.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
38 Tea V, Bonaca M, Chamandi C, Iliou MC, Lhermusier T, Aissaoui N, Cayla G, Angoulvant D, Ferrières J, Schiele F, Simon T, Danchin N, Puymirat E; FAST-MI investigators. Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registry. Eur J Prev Cardiol 2019;26:411-9. [PMID: 30354737 DOI: 10.1177/2047487318808638] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
39 Khan SU, Singh M, Lone AN, Khan MS, Fatima U, Saad AB, Riaz H, Opoku-Asare I, Kaluski E. Meta-analysis of long-term outcomes of percutaneous coronary intervention versus medical therapy in stable coronary artery disease. Eur J Prev Cardiol 2019;26:433-6. [PMID: 30226394 DOI: 10.1177/2047487318800511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
40 Wienbergen H, Fach A, Meyer S, Meyer J, Stehmeier J, Backhaus T, Michel S, Krämer K, Osteresch R, Schmucker J, Haase H, Härle T, Elsässer A, Hambrecht R. Effects of an intensive long-term prevention programme after myocardial infarction - a randomized trial. Eur J Prev Cardiol 2019;26:522-30. [PMID: 29911893 DOI: 10.1177/2047487318781109] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
41 Wenger NK, Doherty CL, Gurwitz JH, Hirsch GA, Holmes HM, Maurer MS, Murray MD. Optimization of Drug Prescription and Medication Management in Older Adults with Cardiovascular Disease. Drugs Aging 2017;34:803-10. [DOI: 10.1007/s40266-017-0494-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]